ARCHIVES

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

Cervarix Vaccine Approved To Prevent Cervical Cancer

October 30, 2009

Pitot Named New NCAB Chairman

May 4, 1979

Mayer Will Emphasize Rehab Research While Serving On NCAB

May 24, 1991

NCCS Networker Volume 6 Issue 1, Winter 1992

January 13, 1992